A. G. Polivanova et al. / Tetrahedron Letters 51 (2010) 4205–4207
4207
R2
R
N
HN
N3
N
R1
R2
N
R1
N3
-HF
H2O
R1
F
N
N
R1-CF2-N3
R2 -NH2
+
R2
1
R1-CF2-NH-R2
R1
HN
O
2
Scheme 3. Probable reaction pathways leading to the formation of 1 and 2.
O
plementary data for compounds 1a, 1e, 1b, 1c, 1h, and 1fa, respec-
tively. These data can be obtained free of charge from The
r.t.
+
CF2CF2N3
HN
THF
CH3O
A-2
O
O
O
N
CF2CF2N3
CH3O
CF2
N
+
3
A-3
References and notes
Scheme 4. Products of the reaction of azepane with A-2 (A-2 to azepane ratio = 1:3,
ratio of A-3:3 = 3:1).
1. Gross, E. G.; Featherstone, R. M. J. Pharm. Exp. Ther. 1946, 87, 299.
2. Beusen, D. D.; Zabrocki, J.; Slomczynska, U.; Head, R. D.; Kao, J. L.-F.; Marshall,
G. R. Biopolymers 1995, 36, 181.
3. Myznikov, L. V.; Hrabalek, A.; Koldobskii, G. I. Chem. Heterocycl. Compd. 2007,
43, 1.
ROH
CF2=CF-CF3
+
NaN3
N3-CF2-CHF-CF3
+
RONa (1)
(2)
4. Nelson, D. W.; Gregg, R. J.; Kort, M. E.; Perez-Medrano, A.; Voight, E. A.; Wang,
Y.; Grayson, G.; Namovic, M. T.; Donnelly-Roberts, D. L.; Niforatos, W.; Honore,
P.; Jarvis, M. F.; Faltynek, C. R.; Carroll, W. A. J. Med. Chem. 2006, 49, 3659.
5. Srihari, P.; Dutta, P.; Srinivasa Rao, R.; Yadav, J. S.; Chandrasekhar, S.;
Thombare, P.; Mohapatra, J.; Chatterjee, A.; Jain, M. R. Bioorg. Med. Chem. Lett.
2009, 19, 5569.
6. Ortar, G.; Moriello, A. S.; Cascio, M. G.; De Petrocellis, L.; Ligresti, A.; Morera, E.;
Nalli, M.; Di Marzo, V. Bioorg. Med. Chem. Lett. 2008, 18, 2820.
7. Frija, L. M. T.; Khmelinskii, I. V.; Cristiano, M. L. S. Tetrahedron Lett. 2005, 46,
6757.
ROH
-HF
CHClF-CF2-NEt2
FClHC-CO-NEt2
+ RF
Scheme 5. Behaviour of 1,1-difluoroazides and Yarovenko–Ishikawa reagents in
alcohols.
resulting azide molecule (Eq. 1, Scheme 5).20f The reactivity of
difluoroazides differs greatly from that of other N–CF2-containing
compounds (Yarovenko–Ishikawa reagents) which react vigor-
ously with alcohols (Eq. 2, Scheme 5).23
In conclusion, the reported results describe a novel reaction pat-
tern for tetrazole ring synthesis (Scheme 1, Eq. 3). This method
should be suitable for the insertion of diverse substituents into a
tetrazole ring.
8. Jankowski, P.; Plesniak, K.; Wicha, J. Org. Lett. 2003, 5, 2789.
9. Potts, D.; Stevenson, P. J.; Thompson, N. Tetrahedron Lett. 2000, 41, 275.
10. (a) Koldobskii, G. I.; Ostrovskii, V. A. Russ. Chem. Rev. 1994, 63, 797; (b) Butler,
R. N.. In Comprehensive Heterocyclic Chemistry; Katritzky, A. R., Rees, C. W., Eds.;
Pergamon: Oxford, UK, 1984; Vol. 5, pp 791–838.
11. Katritzky, A. R.; Cai, C.; Meher, N. K. Synthesis 2007, 1204.
12. Hajra, S.; Sinha, D.; Bhowmick, M. J. Org. Chem. 2007, 72, 1852.
13. Yue, T.; Wang, M.-X.; Wang, D.-X.; Zhu, J. Angew. Chem., Int. Ed. 2008, 47, 9454.
14. (a) Gaponik, P. N.; Karavai, V. P.; Grigor’ev, Y. V. Chem. Heterocycl. Compd. 1985,
21, 1255; (b) Su, W.-K.; Hong, Z.; Shan, W.-G.; Zhang, X.-X. Eur. J. Org. Chem.
2006, 2723.
A typical experimental procedure is as follows: azide A-1
(0.95 g, 5 mmol) and cyclohexylamine (2 g, 20 mmol) were stirred
in 50 mL of dry EtOH for 8 h. The reaction was quenched with
100 mL of 5% aqueous NaHCO3 and the reaction mixture was ex-
tracted with EtOAc (2 Â 20 mL). The combined extracts were dried
over Na2SO4 and the solvent was evaporated. LC–MS analysis of the
resulting oil revealed the presence of two products in a 3:2 ratio.
The target 1-cyclohexyl-5-(1,2,2,2-tetrafluoroethyl)tetrazole was
separated by column chromatography (SiO2, hexane/EtOAc = 10:1),
crystallized from EtOH, and then dried in vacuo. Compound 1a was
isolated as a white crystalline powder (0.75 g, 60%), mp 54–55 °C.
In almost all the experiments the oily products 2 had very low Rf
values and decomposed during purification.
15. (a) Carpenter, W. R. J. Org. Chem. 1962, 27, 2085; (b) Norris, W. P. J. Org. Chem.
1962, 27, 3248.
16. (a) Peterman, K. E.; Sheeve, J. M. J. Fluorine Chem. 1975, 6, 83; (b) Bailey, A. R.;
Banks, R. E. J. Fluorine Chem. 1984, 24, 117.
17. Kotoris, C. C.; Chen, M.-J.; Taylor, S. D. J. Org. Chem. 1998, 63, 8052.
18. Chen, M.-J.; Taylor, S. D. Tetrahedron Lett. 1999, 40, 4149.
19. (a) Ismail, F. M. D. J. Fluorine Chem. 2002, 118, 27; (b) Hagmann, W. K. J. Med.
Chem. 2008, 51, 4359.
20. (a) Knunyants, I. L.; Bykhovskaya, E. G. Dokl. Akad. Nauk. SSSR 1960, 131, 1338;
(b) Banks, R. E.; Moore, G. J. J. Chem. Soc. 1966, 24, 2304; (c) Krespan, C. G. J. Org.
Chem. 1986, 51, 332; (d) Krespan, C. G. J. Am. Chem. Soc. 1984, 106, 5544; (e)
Haas, A.; Spitzer, M.; Lieb, M. Chem. Ber. 1988, 121, 1329; (f) Lermontov, S. A.;
Sukhojenko, I. I.; Popov, A. V.; Pushin, A. N.; Martynov, I. V.; Zefirov, N. S.; Stang,
P. J. Heteroatom Chem. 1993, 4, 579.
21. Cleaver, C. S.; Krespan, C. G. J. Am. Chem. Soc. 1965, 87, 3716.
22. (a) Lermontov, S. A.; Shkavrov, S. V.; Pushin, A. N. J. Fluorine Chem. 2000, 105,
141; (b) Lermontov, S. A.; Shkavrov, S. V.; Pushin, A. N.; Tkachev, V. V. Russ. J.
Gen. Chem. 2002, 72, 1289.
23. (a) Yarovenko, N. N.; Raksha, M. A. Zh. Obshch. Khim. 1959, 29, 2159; (b)
Takaoko, A.; Iwakiri, H.; Ishikawa, N. Bull. Chem. Soc. Jpn. 1979, 52, 3377.
Supplementary data
Characterization data for all new compounds as well as X-ray
studies results are available. CCDC 762986–762991 contain the sup-